Trials / Unknown
UnknownNCT04366180
Evaluation of the Probiotic Lactobacillus Coryniformis K8 on COVID-19 Prevention in Healthcare Workers
Multicentric Study to Assess the Effect of Consumption of Lactobacillus Coryniformis K8 on Healthcare Personnel Exposed to COVID-19
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 314 (estimated)
- Sponsor
- Biosearch S.A. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Accepted
Summary
The aim of the present study is to evaluate the effects of Lactobacillus coryniformis K8 consumption on the incidence and severity of Covid-19 in health workers exposed to the virus. This is a preventive study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotic | The probiotic group will received one capsule with Lactobacillus K8 per day (3x10\^9 cfu/day) during 2 months |
| DIETARY_SUPPLEMENT | Control | The control group will received one placebo capsule per day during 2 months |
Timeline
- Start date
- 2020-04-24
- Primary completion
- 2020-06-01
- Completion
- 2020-10-01
- First posted
- 2020-04-28
- Last updated
- 2020-04-30
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04366180. Inclusion in this directory is not an endorsement.